Volume 10, Number 1—January 2004
Research
Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from Pigs to Humans, Taiwan
Table 3
Ciprofloxacin susceptibility (μg/mol) | MIC | Mutation at | Genotype: genosubtype (N) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
gyrA gene | parC gene | acrR gene | ||||||||
Ser83Phe Asp87Asn (N) | Ser83Phe (N) | Asp87Asn (N) | Ser83Tyr (N) | Asp87Gyr (N) | Ser80Ile (N) | Gln78Stp (N) | Arg107Cys (N) | Ser83Phe (N) | ||
Humans | ||||||||||
Resistant (11) | 16–64 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | A (1); B (10): B1 (2), B2 (2), B3 (2), B4 (1), B5 (2), B6 (1) |
Susceptible (5) | 0.03–0.25 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | C (1), D (1), E (1), F (1), G (1) |
Pigs | ||||||||||
Resistant (5) | 64 | 5 | 5 | 0 | 0 | 0 | 5 | 5 | 0 | 0 B (5): B2 (1), B5 (1), B8 (1), B9 (2) |
Susceptible or intermediate (8) | 0.5–2 | 0 | 1 | 1 | 2 | 4 | 0 | 0 | 0 | B (2): B7 (1), B10 (1); H (1), I (1), J (3), K (1) |
aN = 16.
bN = 13.
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.